New abbreviation here to become acquainted with (PGx) which is pharmacogenics, and one more move in the direction of personalized medicine by big Pharma as the marketing of blockbuster drugs slowly evolves to a new business model with genomic data input becoming a part of the process to bring new drugs...
Posted to
The Medical Quack .... by Barbara Duck
on 11-06-2008
Filed under: Medically Related, Technology, personalized medicine, Genomics, healthcare, Pharma, Pharmacogenomics, Lilly, Pharmacogenetics
Genomics is back on the list for Congress, with creating an additional new agency and a focus on collecting the necessary information to allow research and development. Also included would be guidelines and rules related to genetic and pharmacogenomic tests to bring both Pharma and medical...
Posted to
The Medical Quack .... by Barbara Duck
on 09-12-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Congress, Pharmacogenomics
More business action with big pharma and the biotech industry, although Roche and Genentech already are invested together and have worked on conjunction on research projects. Roche acquired a majority in Genentech in 1990 and currently owns 55.9% of all outstanding shares. Roche...
Posted to
The Medical Quack .... by Barbara Duck
on 07-21-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Pharma, Pharmacogenomics, Bio Tech, Genentech, Roche